Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2018 Aug;25(8):2172-2177. doi: 10.1245/s10434-018-6370-4. Epub 2018 Feb 22.
Prognostic models are increasingly being made available online, where they can be publicly accessed by both patients and clinicians. These online tools are an important resource for patients to better understand their prognosis and for clinicians to make informed decisions about treatment and follow-up. The goal of this analysis was to highlight the possible variability in multiple online prognostic tools in a single disease.
To demonstrate the variability in survival predictions across online prognostic tools, we applied a single validation dataset to three online melanoma prognostic tools. Data on melanoma patients treated at Memorial Sloan Kettering Cancer Center between 2000 and 2014 were retrospectively collected. Calibration was assessed using calibration plots and discrimination was assessed using the C-index.
In this demonstration project, we found important differences across the three models that led to variability in individual patients' predicted survival across the tools, especially in the lower range of predictions. In a validation test using a single-institution data set, calibration and discrimination varied across the three models.
This study underscores the potential variability both within and across online tools, and highlights the importance of using methodological rigor when developing a prognostic model that will be made publicly available online. The results also reinforce that careful development and thoughtful interpretation, including understanding a given tool's limitations, are required in order for online prognostic tools that provide survival predictions to be a useful resource for both patients and clinicians.
预后模型越来越多地在网上提供,患者和临床医生都可以公开访问这些在线工具。这些在线工具是患者更好地了解自身预后的重要资源,也是临床医生在治疗和随访方面做出明智决策的重要资源。本分析的目的是强调单一疾病中多个在线预后工具之间可能存在的差异。
为了展示在线预后工具中生存预测的可变性,我们将一个验证数据集应用于三个在线黑色素瘤预后工具。回顾性收集了 2000 年至 2014 年在纪念斯隆凯特琳癌症中心治疗的黑色素瘤患者的数据。使用校准图评估校准,使用 C 指数评估区分度。
在这个演示项目中,我们发现三个模型之间存在重要差异,导致工具之间个别患者的预测生存存在差异,尤其是在预测范围较低的情况下。在使用单机构数据集的验证测试中,三个模型的校准和区分度存在差异。
这项研究强调了在线工具内部和跨工具之间的潜在可变性,并强调了在开发将在线公开提供的预后模型时采用严格方法的重要性。研究结果还强调,为了使提供生存预测的在线预后工具成为患者和临床医生的有用资源,需要仔细开发和深思熟虑的解释,包括了解给定工具的局限性。